American Society of Hematology

Hematologic Drug Shortage Information


Updated on: April 18, 2016

ASH continues to work with Congress, federal agencies, and other stakeholders to ensure continued access to safe and effective hematologic drugs.

New Updates on Hematologic Drug Shortages

FDA Reports National Shortage of Tretinoin Capsules is RESOLVED

The FDA reported to ASH that the national shortage of tretinoin capsules (Vesanoid; all-trans retinoic acid [ATRA]) has been resolved.  CHEPLAPHARM, Par Pharmaceutical, and Teva Pharmaceutical have tretinoin capsules available for distribution. The shortage started in mid-February and was alarming to ASH members as it is a critical therapy for patients with acute promyelocytic leukemia (APL). ASH applauds the FDA for taking the important steps to mitigate the situation in a timely manner. ASH will continue to monitor the availability of the product and will alert members of any future supply issues. If you are still experiencing supply issues, please contact the FDA at drugshortages@fda.hhs.gov or by phone at 301-796-3400.

back to top

Current Hematologic Drug Shortages

back to top

Recently Resolved Hematologic Drug Shortages

back to top

Additional Resources

back to top

ASH's Comments to Congress and the U.S. Food and Drug Administration

back to top

Media Coverage of Drug Shortages

back to top